ArticleBMC health services research2025
Estimating the societal costs and benefits of de-implementation of low-value care: developing a modelling approach through case assessment.
Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A qualitative study of the reimplementation of a standardised paediatric early warning system pilot in England.Implementation science communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundPrevious estimates of potential costs savings from de-implementation of low-value care have been calculated with simple modelling approaches, focused on direct medical costs and did not take substitution into account. Therefore, the aim of this study was to develop and evaluate a modelling approach to calculate a more realistic estimate of societal costs and benefits of de-implementation of low-value care.
methodsThe modelling approach was developed and evaluated in three steps: (1) review of reviews to identify aspects that may affect the costs and benefits of de-implementation, (2) selection of three cases of low-value care, (3) development and evaluation of the modelling approach for each case. Desk research and interviews with actors were used in step 3 to define input parameters.
resultsThe modelling approach was build and evaluated for the following cases: (1) surgery for achilles tendon rupture, (2) mammography for women < 30 years with focal breast complaints, and (3) imaging for non-specific low back pain. From the interviews, it appeared that case 2 had already been fully disinvested. Hence, calculating the societal costs and benefits for this case was not considered valuable. For case 1 and 3 it was considered valuable and feasible to calculate the societal costs and benefits. Compared to the adapted societal business case approach used in case 1, the adapted societal cost-benefit analysis approach used for case 3 provided a more realistic and better estimate.
conclusionsIt is feasible to calculate a more elaborate and realistic estimate of societal costs and benefits of the de-implementation of low-value care than previous estimates. Nevertheless, it was not feasible to include the costs of de-implementation itself as these are highly reliant on the specific de-implementation strategy employed, which is context specific. Furthermore, the time needed to calculate a more elaborate and realistic estimate stresses the need to carefully select low-value care cases for which the value of calculating such an elaborate and realistic estimate outweighs the effort required to do so.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.